China Pharmaceutical Chain Industry Report, 2006

Publication Date	August 2006
Publisher	Research in China
Product Type	Report
Pages	158
ISBN Number	not applicable
Product Code	RIC00018

Buy this product or for assistance call +44 20 7060 7474

PDF £900.00$1497 | €1007

FAX Order above formats by FAX

Summary

The market size of top 100 China's chain drugstores (by sales) got continuously expanded in 2005, increased to RMB 34.42 billion from RMB 23.24 billion in 2004. By 2005, the shops number of top 100 enterprises totalled 36,240. The potential advantages of chain and scale in China's pharmaceuticals retail industry are becoming apparent.

It has been discovered that great changes have taken place in China's pharmaceuticals market structure by 2004. Over the past years, 90% of drugs are sold by hospitals and only 10% in drugs retail market. Nowadays, the shares of drugs in retail market are up to 20% to 30%.

Based on a great deal of data from National Bureau of Statistics, National Development and Reform Commission, China Association of Pharmaceutical Commerce, State Food and Drug Administration(SFDA), Chinese Pharmaceutical Association, Southern Medical Economic Institute, China Chain Store & Franchise Association, China Business Information Centre, China Drug Store Magazine, China Pharmaceutical Intelligence and other relevant resources, this report analyses the status quo of development, investment characteristics, industrial trend of China pharmaceutical chain industry, focusing on analysing competition of leading pharmaceutical chain enterprises, status of foreign capitals, entry mechanisms to pharmaceutical chain industry and investment opportunities. It also describes market competition pattern in pharmaceutical chain industry, China's industrial policies and policy trend, giving full details about status quo of pharmaceutical chain industry in key regions, like Beijing, Shanghai and Guangzhou.

Content

1. Status quo of development of China's pharmaceutical industry
- 1.1 Status quo of development
  - 1.1.1 Increasing market demand
  - 1.1.2 Fierce market competition
  - 1.1.3 Integration of pharmaceutical industry
  - 1.1.4 Construction of logistic & distribution center speeds up
- 1.2 Analysis on economic benefits of China's pharmaceutical industry
  - 1.2.1 Analysis on overall operations, 2005
  - 1.2.2 Analysis on supply and demand, 2005
  - 1.2.3 Analysis on market operation, 2006
- 1.3 Market status quo of China's pharmaceutical industry
  - 1.3.1 Analysis on demand and structure
    - 1.3.1.1 Growth trend of market demand for pharmaceuticals
    - 1.3.1.2 New changes of drug consumption structure
    - 1.3.1.3 Diversification of pharmaceutical market structure
    - 1.3.1.4 Development trend of blockbuster drugs
  - 1.3.2 Analysis on drug price
    - 1.3.2.1 Drug price turns out to be reasonable
    - 1.3.2.2 Key factors to lower drug price
    - 1.3.2.3Trend of drug price cut, 2006
  - 1.3.3 Analysis on OTC Consumption
    - 1.3.3.1 Analysis on consumer behavior in OTC market
    - 1.3.3.2 Large potential of OTC
- 2. Status quo of China's pharmaceutical chain industry
  - 2.1 Status quo of development
    - 2.1.1 China pharmaceutical retail industry overview
    - 2.1.2 Development dilemma of China's pharmaceutical chain industry
    - 2.1.3 Development review of pharmaceutical chain industry, 2005
    - 2.1.4 10 key words about industrial development, 2005
    - 2.1.5 Threshold to restrict the development of pharmaceutical chain industry
    - 2.1.6 Foreign capitals move into pharmaceutical chain industry
  - 2.2 Status quo of policies of China's pharmaceutical chain industry
    - 2.2.1 Policy background for rapid development of China's pharmaceutical chain industry
    - 2.2.2 Guidance on deepening pharmaceutical circulation system reform
      - 2.2.2.1 Guiding ideology
      - 2.2.2.2 Reform objectives
      - 2.2.2.3 Policies and measures
    - 2.2.3 Online drugstores to pass acceptance inspection
    - 2.2.4 Policy support of pharmaceutical retail industry
      - 2.2.4.1 Policy support
      - 2.2.4.2 Development of pharmaceutical retail industry
    - 2.2.5 Relevant policies to be issued
      - 2.2.5.1 SFDA: issue regulations on setup of medicine cabinet in remote rural areas
      - 2.2.5.2 Ministry of Public Health: reinstate system for doctors to prescribe with generic name
      - 2.2.5.3 SFDA: establish a system for adjusting drug prices biennially
      - 2.2.5.4 Notice of General Office of the State Council on stabilizing housing price to touch medical system
      - 2.2.5.5 National Development and Reform Commission intends to label drug price on external package
      - 2.2.5.6 Policy factors of development dilemma of pharmaceutical industry
  - 3. Analysis on regional pharmaceutical chain market in China
    - 3.1 Status quo of pharmaceutical chain market competition in Beijing
      - 3.1.1 Different performances
      - 3.1.2 Beijing chain drugstores return to direct selling
    - 3.2 Overview of pharmaceutical chain market in Shanghai
      - 3.2.1 Fierce competition of out-of-town pharmaceutical chain stores in Shanghai
      - 3.2.2 Shanghai low-price drugstores to suffer loss
    - 3.3 Status quo of pharmaceutical chain market competition in Guangdong province
      - 3.3.1Status quo of pharmaceutical retail market in Guangzhou
      - 3.3.2 GSP attestation of retail drugstores in Guangdong province
      - 3.3.3 Status quo of pharmaceutical retail market competition in Shenzhen
    - 3.4 Overview of pharmaceutical chain market in Hunan province
      - 3.4.1 Pharmaceutical chain stores in Changsha no longer only play price war game
      - 3.4.2 Analysis on outstanding performance of "Laobaixing"
    - 3.5 Status quo of pharmaceutical chain market competition in other cities
      - 3.5.1 Analysis on retail drugstores competition in Fuzhou
      - 3.5.2 Market analysis on chain drugstores in Harbin
      - 3.5.3 Overview of retail drugstores market in Shenyang
      - 3.5.4 Overview of retail drugstores market in Chengtu
      - 3.5.5 Overview of retail drugstores market in Hangzhou
      - 3.5.6 Market analysis on retail drugstores in Lanzhou
      - 3.5.7 Market analysis on retail drugstores in Haikou
  - 4. Analysis on China's leading pharmaceutical chain enterprises
    - 4.1 Overview
      - 4.1.1 Development status of China's chain drugstores, 2004-2005
      - 4.1.2 Status of listed pharmaceutical companies to operate pharmaceutical chain business
    - 4.2 Analysis on relevant listed pharmaceutical companies
      - 4.2.1 Neptunus
      - 4.2.2 Guangzhou Pharmaceutical Company Limited
      - 4.2.3 Shenzhen Accord Pharmaceutical Co., Ltd.
      - 4.2.4 Tianjin Zhongxin Pharmaceutical Group Corporation Limited
      - 4.2.5 Chongqing Tong Jun Ge Co., Ltd.
      - 4.2.6 Shanghai Pharmaceutical Group Co., Ltd.
      - 4.2.7 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
      - 4.2.8 LIVZON Pharmaceutical Group Inc.
      - 4.2.9 Harbin Pharmaceutical Group Co., Ltd.
      - 4.2.10 Jiuzhitang Co., Ltd
      - 4.2.11 Beijing Tongrentang Co., Ltd
    - 4.3 Strategy analysis on listed companies' investment into pharmaceutical chain industry
    - 4.4 Analysis on large-sized enterprises in pharmaceutical chain industry
      - 4.4.1 China Nepstar Chain Drugstore Ltd.
      - 4.4.2 Hunan Zhilin Pharmaceutical Chain Stores Co., Ltd
      - 4.4.3 Jilin Pharmacy Chain Co., Ltd
      - 4.4.4 Yixintang Pharmaceutical Chain Co., Ltd
      - 4.4.5 Gansun Zhongyou Pharmaceutical Group
      - 4.4.6 Hunan Laobaixing Pharmacy Chain Co. Ltd
      - 4.4.7 Liaoning Chengda Fangyuan Pharmaceutical Chain Co., Ltd
      - 4.4.8 Hubei Tongjitang Pharmacy Co., Ltd
      - 4.4.9 Guangdong Bencao
      - 4.4.10 Shanghai Huashi Pharmacy Co., Ltd
      - 4.4.11 Shenzhen Accord Pharmaceutical Co., Ltd
      - 4.4.12 Beijing Golden Elephant Pharmacy Chain Stores Co. Ltd
      - 4.4.13 Guizhou Yishu Pharmaceutical Chain Stores Co., Ltd
      - 4.4.14 Jiangxi Kaixinren Pharmaceutical Chain Stores Co., Ltd
      - 4.4.15 Tongrentang
      - 4.4.16 Tongjunge
      - 4.4.17 Shenzhen Zhonglian Chain Drugstores Co., Ltd
      - 4.4.18 Hunan Jinsha Chain Drugstores Co., Ltd
      - 4.4.19 Sanjiu Chain Drugstores Co., Ltd
      - 4.4.20 Medicine Shoppe
  - 5. Development trends of chain drugstores
    - 5.1 Diversification of chain drugstores
      - 5.1.1 Status quo of diversification of China's chain drugstores
      - 5.1.2 Difficulties of diversification of China's chain drugstores
      - 5.1.3 Directions of business choice of drugstores' diversification
    - 5.2 Chain drugstores enter Post Economic Times in 2006
    - 5.3 Merger and integration of chain drugstores to accelerate
      - 5.3.1 Merger of chain drugstores in international market
      - 5.3.2 Merger of China's chain drugstores
    - 5.4 Development trend of pharmaceutical retail industry
      - 5.4.1 Next stop of professional drugstore-medicine cosmetics store
      - 5.4.2 Pharmaceutical tycoon to be optimistic of medicine cosmetics
  - Production growth of sub-industry in pharmaceutical manufacturing, 2004- Dec.2005
  - Production proportion of sub-industry in pharmaceutical manufacturing, 2005
  - Growth of economic benefits of pharmaceutical enterprises by ownership, 2005
  - Analysis on overall economic benefits of pharmaceutical manufacturing, 2004-2005
  - Profit growth of pharmaceutical manufacturing and sub-industry (1), 2004-2005
  - Profit growth of pharmaceutical manufacturing and sub-industry (2), 2004-2005
  - Analysis on profit margin of pharmaceutical manufacturing and sub-industry (1), 2004-2005
  - Analysis on profit margin of pharmaceutical manufacturing and sub-industry (2), 2004-2005
  - Economic benefits data of pharmaceutical manufacturing and sub-industry, Jan. 2005-Dec.2005
  - Accumulated profits and growth of pharmaceutical manufacturing and sub-industry, 2005
  - Rankings of Gross output value of China's pharmaceutical industry by region, 2005
  - Top 10 China's pharmaceutical enterprises by sales, 2005
  - Top 10 China's pharmaceutical enterprises by profits, 2005
  - Cost analysis on pharmaceutical manufacturing and sub-industry (1), 2004-2005
  - Cost analysis on pharmaceutical manufacturing and sub-industry (2), 2004-2005
  - Profit margin of cost and expenses pharmaceutical manufacturing and sub-industry (1), 2004-2005
  - Profit margin of cost and expenses of pharmaceutical manufacturing and sub-industry (2), 2004-2005
  - Indexes of expenses of pharmaceutical manufacturing and sub-industry, 2005
  - Growth of administration charges and financial expenses of pharmaceutical manufacturing and sub-industry, 2005
  - Assets-liability ratio of pharmaceutical manufacturing and sub-industry, 2004-2005
  - Growth of account receivable of pharmaceutical manufacturing and sub-industry (1), 2004-2005
  - Growth of account receivable of pharmaceutical manufacturing and sub-industry (2), 2004-2005
  - Growth of assets-liability ratio and account receivable of pharmaceutical manufacturing and sub-industry, Dec. 2005
  - Cash ratio of pharmaceutical manufacturing and sub-industry, 2004-2005
  - Year-on-year growth rate of chemical raw material medicine output, 2004-Dec.2005
  - Year-on-year growth rate of Chinese patent drugs output, 2004-Dec.2005
  - Sales and storage of pharmaceutical industry, 2004-2005
  - Sales revenue and profit concentration ration of pharmaceutical manufacturing and sub-industry, 2005
  - Growth of economic benefits of enterprises in pharmaceutical manufacturing and sub-industry (by scale), 2005
  - Sales proportion of enterprises in pharmaceutical industry by ownership, 2005
  - Proportion of total profits of enterprises in pharmaceutical industry by ownership, 2005
  - Development status of pharmaceutical industry, Q1 2006
  - Exports of pharmaceutical industry, Q1 2006
  - Economic benefits of pharmaceutical industry, Q1 2006
  - Statistics of economic benefits of 22 leading state-owned pharmaceutical enterprises, Q1 2006
  - Major 10 blockbuster drugs in China, 2004
  - Major 10 blockbuster drugs worldwide and sales, 2002
  - Major 10 blockbuster drugs worldwide and sales, 2003
  - Major 10 blockbuster drugs worldwide, 2005
  - Information source of OTC consumption
  - Growth of total sales of Top100 pharmaceutical chain enterprises (1), 2002-2005
  - Growth of total sales of Top100 pharmaceutical chain enterprises (2), 2002-2005
  - Sales comparison among pharmaceutical chain enterprises with different ranking, 2004-2005
  - Share changes of total sales of Top 10 pharmaceutical chain enterprises (1), 2003-2005
  - Share changes of total sales of Top 10 pharmaceutical chain enterprises (2), 2003-2005
  - Development status of Hubei Tongjitang Chain Drugstore, 2003-2005
  - Growth of Top 100 chain drugstores, 2004-2005
  - Development status of Top 3 pharmaceutical chain enterprises by sales, 2005
  - Development status of China Nepstar Chain Drugstore Ltd., 2004-2005
  - Rankings of pharmaceutical chain enterprises, 2005
  - List of Top 100 China's chain drugstores (by scale), 2005
  - List of Top 100 China's chain drugstores (by overall ranking), 2006
  - List of Top 100 China's chain drugstores (by scale), 2006
  - Profit distribution of Neptunus, 2005-2006
  - Profitability of Neptunus, 2005-2006
  - Management competence of Neptunus, 2005-2006
  - Development capacity of Neptunus, 2005-2006
  - Profit distribution of Guangzhou Pharmaceutical Company Limited, 2005-2006
  - Profitability of Guangzhou Pharmaceutical Company Limited, 2005-2006
  - Management competence of Guangzhou Pharmaceutical Company Limited, 2005-2006
  - Development capacity of Guangzhou Pharmaceutical Company Limited, 2005-2006
  - Profit distribution of Shenzhen Accord Pharmaceutical Co., Ltd., 2005-2006
  - Management competence of Shenzhen Accord Pharmaceutical Co., Ltd., 2005-2006
  - Development capacity of Shenzhen Accord Pharmaceutical Co., Ltd., 2005-2006
  - Profit distribution of Tianjin Zhongxin Pharmaceutical Group Corporation Limited, 2005-2006
  - Profitability of Tianjin Zhongxin Pharmaceutical Group Corporation Limited, 2005-2006
  - Management competence of Tianjin Zhongxin Pharmaceutical Group Corporation Limited, 2005-2006
  - Development capacity of Tianjin Zhongxin Pharmaceutical Group Corporation Limited, 2005-2006
  - Profit distribution of Chongqing Tong Jun Ge Co., Ltd, 2005-2006
  - Profitability of Chongqing Tong Jun Ge Co., Ltd, 2005-2006
  - Management competence of Chongqing Tong Jun Ge Co., Ltd, 2005-2006
  - Development capacity of Chongqing Tong Jun Ge Co., Ltd, 2005-2006
  - Profit distribution of Shanghai Pharmaceutical Group Co., Ltd., 2005-2006
  - Profitability of Shanghai Pharmaceutical Group Co., Ltd., 2005-2006
  - Management competence of Shanghai Pharmaceutical Group Co., Ltd., 2005-2006
  - Development capacity of Shanghai Pharmaceutical Group Co., Ltd., 2005-2006
  - Profit distribution of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., 2005-2006
  - Profitability of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., 2005-2006
  - Management competence of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., 2005-2006
  - Development capacity of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., 2005-2006
  - Profit distribution of LIVZON Pharmaceutical Group Inc., 2005-2006
  - Profitability of LIVZON Pharmaceutical Group Inc., 2005-2006
  - Management competence of LIVZON Pharmaceutical Group Inc., 2005-2006
  - Development capacity of LIVZON Pharmaceutical Group Inc., 2005-2006
  - Profit distribution of Harbin Pharmaceutical Group Co., Ltd., 2005-2006
  - Profitability of Harbin Pharmaceutical Group Co., Ltd., 2005-2006
  - Management competence of Harbin Pharmaceutical Group Co., Ltd., 2005-2006
  - Development capacity of Harbin Pharmaceutical Group Co., Ltd., 2005-2006
  - Profit distribution of Jiuzhitang Co., Ltd, 2005-2006
  - Profitability of Jiuzhitang Co., Ltd, 2005-2006
  - Management competence of Jiuzhitang Co., Ltd, 2005-2006
  - Development capacity of Jiuzhitang Co., Ltd, 2005-2006
  - Profit distribution of Beijing Tongrentang Co., Ltd, 2005-2006
  - Profitability of Beijing Tongrentang Co., Ltd, 2005-2006
  - Management competence of Beijing Tongrentang Co., Ltd, 2005-2006
  - Development capacity of Beijing Tongrentang Co., Ltd, 2005-2006